Skip to search.
 TSX Up 0.11% TSX Ventures Down 0.30%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
4.04 Down 0.08(1.94%) 3:59PM EDT
Prev Close:4.12
Open:4.10
Bid:4.04 x 100
Ask:4.09 x 200
1y Target Est:16.00
Beta:1.29901
Earnings Date:Nov 8 - Nov 14 (Est.)
Day's Range:4.04 - 4.16
52wk Range:2.80 - 10.88
Volume:16,713
Avg Vol (3m):50,819
Market Cap:6.09M
P/E (ttm):N/A
EPS (ttm):-11.50
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
DCTHDown 1.94%6.09M
LLYUp 0.35%83.97B
PFEUp 0.72%212.84B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.72
Quarterly EPS Est (Sep-16) :-3.29
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback